Skip to main content
Clinical Trials/ITMCTR1900002410
ITMCTR1900002410
Not yet recruiting
未知

Multicenter Clinical Observation of Guilonghulou Coating Agent in Prevention and Treatment of Thrombosis of Autologous Arteriovenous Fistula in Hemodialysis Patients

the Second Affiliated Hospital of Guizhou University of Traditional Chinese Medicine0 sitesTBD

Overview

Phase
未知
Intervention
Not specified
Conditions
Failure of autologous arteriovenous fistula
Sponsor
the Second Affiliated Hospital of Guizhou University of Traditional Chinese Medicine
Status
Not yet recruiting
Last Updated
3 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
3 years ago
Study Type
Interventional study
Sex
All

Investigators

Sponsor
the Second Affiliated Hospital of Guizhou University of Traditional Chinese Medicine

Eligibility Criteria

Inclusion Criteria

  • (1\) Patients who meet the diagnostic criteria of uremia stage of chronic renal failure and have been treated with hemodialysis for 3 months or more; (2\) Patients who have undergone autologous arteriovenous fistula surgery and met the maturity criteria of arteriovenous fistula in the first edition of Chinese consensus on vascular access for hemodialysis in 2014, and who have begun to puncture arteriovenous fistula for hemodialysis; (3\) Blood flow of internal fistula can meet the criteria. The hemodialysis blood flow of patients was more than 250ml/min, the age of patients was between 18 and 80 years old, and the gender was not limited. (4\) Informed consent to participate in the study and sign the informed consent.

Exclusion Criteria

  • (1\) Mental disorders, cognitive impairment, unable to cooperate with the study smoothly; (2\) Coagulation dysfunction, with a significant bleeding tendency; (3\) Autoimmune deficiency; (4\) Allergic constitution or allergic to a variety of drugs; and (5\) Poor compliance.

Outcomes

Primary Outcomes

Not specified

Similar Trials